Roots-Analysis-Logo.png
The peptide therapeutics market is projected to be worth around USD 41.7 Billion in 2030, claims Roots Analysis
09 sept. 2021 08h36 HE | Roots Analysis
London, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Peptide Therapeutics Market, 2021 – 2030” report to its list of offerings. Characterized by a rapidly...
TIP_link_300x300.jpg
Peptide Therapeutics Market to Outstrip $50,003.15 Million by 2027 Growing Sturdy at 9.2% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
09 juin 2021 11h13 HE | The Insight Partners
Pune, India., June 09, 2021 (GLOBE NEWSWIRE) -- Peptide Therapeutics Market: Key InsightsAccording to our new research study on “Peptide Therapeutics Market to 2027 – Global Analysis and Forecast –...
photo1
Peptomyc Board of Directors appoints Giacomo Di Nepi as Chairman of the Board
06 janv. 2021 18h00 HE | Peptomyc S.L.
BARCELONA, Spain, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Peptomyc S.L., a biotech company specialized in the development of protein and peptide therapeutics targeting the Myc oncoprotein for cancer...
logo.jpg
Global Peptide Therapeutics Market Size Growth Forecast Sales Clinical Trials Insight 2026
11 nov. 2020 03h36 HE | KuicK Research
DELHI, India, Nov. 11, 2020 (GLOBE NEWSWIRE) -- “Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026” report highlights: Global Peptide Therapeutics Market Opportunity: US$ 65...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma to leverage Intomics bioinformatics platform within peptide drug discovery and development process
10 juin 2020 02h00 HE | Zealand Pharma
Press Release – No. 07 / 2020 Zealand Pharma to leverage Intomics bioinformatics platform within peptide drug discovery and development process The research agreement enhances Zealand Pharma’s...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics
22 oct. 2019 06h05 HE | Zealand Pharma
Company announcement – No. 37 / 2019 Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics                The transaction strengthens the leadership of Zealand Pharma...